fda removes semaglutide shortage list 2025 On February 21, 2025, the announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding FDA Announces End to Semaglutide

Key Health Assessments and Medication Review A thorough medication review is essential

Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society

While these medications have garnered significant acclaim, speculation around appropriate candidates and optimal usage of these medications remains a central topic of discussion

Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms Nicholas Jacobus Key Takeaways Surpass-Early randomized ~800 adults with 4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators

Patients should maintain a diary of meals, symptoms and finger-prick readings to support specialist assessment

This is why ongoing medical monitoring with PlexusDx is critical for thyroid patients pursuing weight loss treatment